Biotechnology company Moderna announced Monday that its coronavirus vaccine candidate appears to be 94.5% effective against the disease. The news comes one week after Pfizer announced that its vaccine was more than 90% effective in a clinical trial. As California rolls back reopening plans amid a spike in cases, we’ll discuss next steps for the new vaccines and what we know about safety and long-term effectiveness.
As Coronavirus Cases Spike, Vaccine News Offers Hope
at 9:40 AM
This creative image taken in a studio in Paris on November 16, 2020, showing a syringe and a vaccine vial with the reproducted logo of a US biotech firm Moderna, illustrates the announcement of an experimental vaccine against Covid-19 from Moderna that would be nearly 95% effective. (JOEL SAGET/AFP via Getty Images)
Damian Garde, National Biotech Reporter, Stat